bivalirudin monotherapy

Related by string. * Bivalirudin : Angiomax bivalirudin . bivalirudin alone . R bivalirudin . bivalirudin / Monotherapy : methotrexate monotherapy . artemisinin monotherapy . Lucentis monotherapy . REMICADE monotherapy . Tysabri monotherapy . metformin monotherapy . infliximab monotherapy . Xeloda monotherapy . rituximab monotherapy . receiving Vectibix monotherapy * *

Related by context. Frequent words. (Click for all words.) 66 Taxus Stent 65 DOXIL 63 tamsulosin 63 Pioglitazone 62 Postoperative 62 thromboembolism 62 TAXUS p value 62 unfractionated heparin 62 fondaparinux 62 Lenalidomide 62 bivalirudin 62 Thrombolysis 62 plus dexamethasone 62 confidence interval #.#-#.# 61 XELOX 61 statistically significant p = 61 chlorambucil 61 plus prednisone 60 abciximab 60 TAXUS Stent 60 thromboembolic events 60 P = .# 60 mycophenolate mofetil 60 endarterectomy 60 irbesartan 60 enalapril 60 cerebrovascular events 60 Carotid 59 CI -#.# 59 angiotensin converting enzyme inhibitors 59 Lantus ® 59 μg kg 59 LVEF 58 transurethral resection 58 Clopidogrel 58 dacarbazine 58 placebo p = 58 Acute Myocardial Infarction 58 % CI #.#-#.# [007] 58 Benign Prostatic Hyperplasia 58 platelet inhibition 58 Navelbine 58 lumiracoxib 58 daunorubicin 58 darbepoetin alfa 58 discontinuations due 58 Ann Intern Med 58 Percutaneous Coronary Intervention 58 enoxaparin 58 univariate 58 annualized relapse 58 plus gemcitabine 58 creatinine clearance 58 left ventricular systolic 58 Erlotinib 58 FOLFIRI 57 Pharmacokinetic 57 TAXUS Element Stent 57 glomerular filtration rate 57 sensitivity specificity 57 low dose dexamethasone 57 fluorouracil 57 leukopenia 57 statistically significant p 57 #mg/day [001] 57 infarct size 57 carboplatin paclitaxel 57 % CI #.#-#.# [003] 57 esomeprazole 57 fraction LVEF 57 glimepiride 57 tolvaptan 57 active comparator 57 composite endpoint 57 Ischemic 57 pg ml 57 decitabine 57 D dimer 57 lamotrigine 57 TIMI 57 myocardial infarction stroke 57 ADAS cog 57 CI #.#-#.# [002] 57 systemic embolism 57 stent restenosis 57 mg QD 56 Myocardial 56 Cmax 56 Preoperative 56 Stenting 56 laboratory abnormalities 56 Secondary endpoints included 56 QTc 56 C Reactive Protein 56 ACR# response 56 achieved statistical significance 56 thrombolytics 56 interferon alfa 56 NEXIUM 56 mcg kg 56 univariate analysis

Back to home page